What is Scotiabank's Forecast for Savaria FY2027 Earnings?

Key Points

• Scotiabank raised its FY2027 EPS forecast for Savaria to C$1.51 from C$1.50, above the current consensus estimate of C$1.20.
• Savaria recently reported quarterly EPS of C$0.35 on revenue of C$245.78 million, with a 9.27% net margin and 13.41% return on equity.
• Analyst sentiment remains positive, with the stock carrying an average “Buy” rating and a C$34.33 target price, although insiders sold 81,747 shares worth about C$2.45 million over the past quarter.

Savaria Co. (TSE:SIS - Free Report) - Stock analysts at Scotiabank increased their FY2027 earnings estimates for Savaria in a research report issued to clients and investors on Wednesday, August 19th. Scotiabank analyst J. Goldman now anticipates that the company will post earnings per share of $1.51 for the year, up from their previous estimate of $1.50. The consensus estimate for Savaria's current full-year earnings is $1.20 per share.

Savaria (TSE:SIS - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C$0.35 earnings per share for the quarter. The company had revenue of C$245.78 million for the quarter. Savaria had a net margin of 9.27% and a return on equity of 13.41%.

A number of other research firms have also commented on SIS. TD Securities raised Savaria to a "strong-buy" rating in a research note on Friday, July 24th. Desjardins raised their price target on shares of Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a report on Friday, August 7th. TD boosted their price target on shares of Savaria from C$35.00 to C$37.00 and gave the stock a "buy" rating in a research report on Friday, August 7th. Finally, ATB Cormark Capital Markets increased their price objective on shares of Savaria from C$35.00 to C$38.00 and gave the stock an "outperform" rating in a research report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company's stock. According to data from MarketBeat, Savaria presently has an average rating of "Buy" and an average target price of C$34.33.

Savaria Stock Up 1.0%

Shares of SIS opened at C$28.54 on Friday. The stock's 50-day moving average price is C$29.82 and its two-hundred day moving average price is C$28.14. Savaria has a 12 month low of C$20.10 and a 12 month high of C$31.95. The company has a market capitalization of C$2.06 billion, a PE ratio of 23.59, a PEG ratio of 42.72 and a beta of 1.04. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 29.43.

Insider Activity at Savaria

In other news, Director Jean-Louis Chapdelaine sold 14,898 shares of the firm's stock in a transaction dated Friday, August 7th. The stock was sold at an average price of C$30.24, for a total value of C$450,515.52. Following the completion of the sale, the director directly owned 100,000 shares in the company, valued at C$3,024,000. This trade represents a 12.97% decrease in their position. Also, Director Peter Allen Drutz sold 9,736 shares of the company's stock in a transaction that occurred on Saturday, June 6th. The stock was sold at an average price of C$29.00, for a total value of C$282,344.00. Following the transaction, the director directly owned 95,251 shares in the company, valued at approximately C$2,762,279. This trade represents a 9.27% decrease in their ownership of the stock. Insiders have sold 81,747 shares of company stock worth $2,448,032 over the last quarter. 17.45% of the stock is currently owned by insiders.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source